Selected research
Industry Research
Kinase Biology Services Industry Research Report 2026
Market perspective
The global Kinase Biology Services market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Kinase Biology Services market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Kinase Biology Services market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Kinase Biology Services market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Kinase Biology Services include Roche Holdings, Thermo Fisher Scientific, Jena Bioscience GmbH, Roche Holdings, Qiagen N.V., Merck & Co Company, Promega Corporation, Takara Bio and Anchor. among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Kinase Biology Services market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Kinase Biology Services.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Kinase Biology Services Market by Company
Roche Holdings
Thermo Fisher Scientific
Jena Bioscience GmbH
Roche Holdings
Qiagen N.V.
Merck & Co Company
Promega Corporation
Takara Bio
Anchor
Kinase Biology Services Segment by Type
ELISA Based Tests
Enzymatic Tests
Colorimetric Assay Based Tests
Others
Kinase Biology Services Segment by Application
Diagnosis Use
Research Use
Kinase Biology Services Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Kinase Biology Services market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Kinase Biology Services and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Kinase Biology Services.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Kinase Biology Services companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- ELISA Based Tests
- Enzymatic Tests
- Colorimetric Assay Based Tests
- Others
Applications
- Diagnosis Use
- Research Use
Companies covered
- Roche Holdings
- Thermo Fisher Scientific
- Jena Bioscience GmbH
- Roche Holdings
- Qiagen N.V.
- Merck & Co Company
- Promega Corporation
- Takara Bio
- Anchor
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Kinase Biology Services by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 ELISA Based Tests
- 2.2.3 Enzymatic Tests
- 2.2.4 Colorimetric Assay Based Tests
- 2.2.5 Others
- 2.3 Kinase Biology Services by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Diagnosis Use
- 2.3.3 Research Use
- 2.4 Assumptions and Limitations
3 Kinase Biology Services Breakdown Data by Type
- 3.1 Global Kinase Biology Services Historic Market Size by Type (2021-2026)
- 3.2 Global Kinase Biology Services Forecasted Market Size by Type (2027-2032)
4 Kinase Biology Services Breakdown Data by Application
- 4.1 Global Kinase Biology Services Historic Market Size by Application (2021-2026)
- 4.2 Global Kinase Biology Services Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Kinase Biology Services Market Perspective (2021-2032)
- 5.2 Global Kinase Biology Services Growth Trends by Region
- 5.2.1 Global Kinase Biology Services Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Kinase Biology Services Historic Market Size by Region (2021-2026)
- 5.2.3 Kinase Biology Services Forecasted Market Size by Region (2027-2032)
- 5.3 Kinase Biology Services Market Dynamics
- 5.3.1 Kinase Biology Services Industry Trends
- 5.3.2 Kinase Biology Services Market Drivers
- 5.3.3 Kinase Biology Services Market Challenges
- 5.3.4 Kinase Biology Services Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Kinase Biology Services Players by Revenue
- 6.1.1 Global Top Kinase Biology Services Players by Revenue (2021-2026)
- 6.1.2 Global Kinase Biology Services Revenue Market Share by Players (2021-2026)
- 6.2 Global Kinase Biology Services Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Kinase Biology Services Head Office and Area Served
- 6.4 Global Kinase Biology Services Players, Product Type & Application
- 6.5 Global Kinase Biology Services Manufacturers Established Date
- 6.6 Global Kinase Biology Services Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Kinase Biology Services Market Size (2021-2032)
- 7.2 North America Kinase Biology Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Kinase Biology Services Market Size by Country (2021-2026)
- 7.4 North America Kinase Biology Services Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Kinase Biology Services Market Size (2021-2032)
- 8.2 Europe Kinase Biology Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Kinase Biology Services Market Size by Country (2021-2026)
- 8.4 Europe Kinase Biology Services Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Kinase Biology Services Market Size (2021-2032)
- 9.2 Asia-Pacific Kinase Biology Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Kinase Biology Services Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Kinase Biology Services Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Kinase Biology Services Market Size (2021-2032)
- 10.2 South America Kinase Biology Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Kinase Biology Services Market Size by Country (2021-2026)
- 10.4 South America Kinase Biology Services Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Kinase Biology Services Market Size (2021-2032)
- 11.2 Middle East & Africa Kinase Biology Services Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Kinase Biology Services Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Kinase Biology Services Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Roche Holdings
- 12.1.1 Roche Holdings Company Information
- 12.1.2 Roche Holdings Business Overview
- 12.1.3 Roche Holdings Revenue in Kinase Biology Services Business (2021-2026)
- 12.1.4 Roche Holdings Kinase Biology Services Product Portfolio
- 12.1.5 Roche Holdings Recent Developments
- 12.2 Thermo Fisher Scientific
- 12.2.1 Thermo Fisher Scientific Company Information
- 12.2.2 Thermo Fisher Scientific Business Overview
- 12.2.3 Thermo Fisher Scientific Revenue in Kinase Biology Services Business (2021-2026)
- 12.2.4 Thermo Fisher Scientific Kinase Biology Services Product Portfolio
- 12.2.5 Thermo Fisher Scientific Recent Developments
- 12.3 Jena Bioscience GmbH
- 12.3.1 Jena Bioscience GmbH Company Information
- 12.3.2 Jena Bioscience GmbH Business Overview
- 12.3.3 Jena Bioscience GmbH Revenue in Kinase Biology Services Business (2021-2026)
- 12.3.4 Jena Bioscience GmbH Kinase Biology Services Product Portfolio
- 12.3.5 Jena Bioscience GmbH Recent Developments
- 12.4 Roche Holdings
- 12.4.1 Roche Holdings Company Information
- 12.4.2 Roche Holdings Business Overview
- 12.4.3 Roche Holdings Revenue in Kinase Biology Services Business (2021-2026)
- 12.4.4 Roche Holdings Kinase Biology Services Product Portfolio
- 12.4.5 Roche Holdings Recent Developments
- 12.5 Qiagen N.V.
- 12.5.1 Qiagen N.V. Company Information
- 12.5.2 Qiagen N.V. Business Overview
- 12.5.3 Qiagen N.V. Revenue in Kinase Biology Services Business (2021-2026)
- 12.5.4 Qiagen N.V. Kinase Biology Services Product Portfolio
- 12.5.5 Qiagen N.V. Recent Developments
- 12.6 Merck & Co Company
- 12.6.1 Merck & Co Company Company Information
- 12.6.2 Merck & Co Company Business Overview
- 12.6.3 Merck & Co Company Revenue in Kinase Biology Services Business (2021-2026)
- 12.6.4 Merck & Co Company Kinase Biology Services Product Portfolio
- 12.6.5 Merck & Co Company Recent Developments
- 12.7 Promega Corporation
- 12.7.1 Promega Corporation Company Information
- 12.7.2 Promega Corporation Business Overview
- 12.7.3 Promega Corporation Revenue in Kinase Biology Services Business (2021-2026)
- 12.7.4 Promega Corporation Kinase Biology Services Product Portfolio
- 12.7.5 Promega Corporation Recent Developments
- 12.8 Takara Bio
- 12.8.1 Takara Bio Company Information
- 12.8.2 Takara Bio Business Overview
- 12.8.3 Takara Bio Revenue in Kinase Biology Services Business (2021-2026)
- 12.8.4 Takara Bio Kinase Biology Services Product Portfolio
- 12.8.5 Takara Bio Recent Developments
- 12.9 Anchor
- 12.9.1 Anchor Company Information
- 12.9.2 Anchor Business Overview
- 12.9.3 Anchor Revenue in Kinase Biology Services Business (2021-2026)
- 12.9.4 Anchor Kinase Biology Services Product Portfolio
- 12.9.5 Anchor Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst